AY
Aytu BioPharma, Inc.
AYTU · NASDAQ
$2.19 -1.35% (-$0.03)
1M -7.98%
Market Cap $24.5M
P/E Ratio -
Div. Yield -
ROE 148.91%
Piotroski F-Score Weak
3/9Valuation
93 /100
Cheap P/B 0.70x
P/FCF 14.92x
P/S 0.43x
Growth
0 /100
Declining Book val. growth 24.64%
Rev. growth 11.78%
FCF growth N/A
Profitability
27 /100
Weak Net margin 60.17%
Op. margin 26.79%
FCF margin 2.90%
Quality
6 /100
Poor ROE 148.91%
ROA 30.49%
Asset turnover 0.51x
Debt
44 /100
Moderate Current ratio 1.12x
Int. coverage -14.02x
Debt/Equity 0.65x
Stability
33 /100
Unstable Rev. volatility 26.83%
EPS volatility 35.35%
Profitable years 0
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na AYTU
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Joshua R. Disbrow
Employees
83
Headquarters
Denver
Nadcházející události
22 ZÁŘ
Earnings
Upcoming earnings report
29 ZÁŘ
Earnings
Upcoming earnings report